Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures (Q33591073)

28 July 2017

Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures (English)

1 reference

28 July 2017

0 references

1 reference

Schapel GJ

1

1 reference

28 July 2017

Beran RG

2

1 reference

28 July 2017

Vajda FJ

3

1 reference

28 July 2017

Berkovic SF

4

1 reference

28 July 2017

Mashford ML

5

1 reference

28 July 2017

Dunagan FM

6

1 reference

28 July 2017

Yuen WC

7

1 reference

28 July 2017

Davies G

8

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 May 1993

1 reference

Journal of Neurology, Neurosurgery and Psychiatry

28 July 2017

1 reference

28 July 2017

56

1 reference

28 July 2017

448-453

1 reference

28 July 2017

5

1 reference

Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans

28 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014998

Double-blind crossover trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014998

Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014998

A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014998

Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014998

A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1014998

Lamotrigine: single-dose pharmacokinetics and initial 1 week experience in refractory epilepsy

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8505632

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Controlled trial of lamotrigine (Lamictal) for refractory partial seizures

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/8505632

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/JNNP.56.5.448

1 reference

28 July 2017

1 reference

28 July 2017

1 reference